OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
November 07, 2023
Conference session discusses the drivers, practical considerations, success factors, and landscape for next-generation pharmacy innovation.
Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.
Ayala Pharmaceuticals’ AL102 is a gamma secretase inhibitor being studied to treat patients with desmoid tumors.
Studies with Zenith-CKD showed significant albuminuria reduction.
November 06, 2023
There are a slew of specialist and boutique companies set up to provide high quality services and to meet the changing needs of the pharma industry.
While there are still hurdles to overcome along the way, home healthcare could deliver better patient-centered cancer care, providing improved patient outcomes, enhanced quality of life, and reduced strain on resources.
With new tech acquisition, the software company also introduces a new branded AI assistant for mobile devices specifically for the life sciences sector.
November 03, 2023
Study describes how biotech startups can avoid competing with large pharma companies for financing.
R&D teams need to accelerate how they conduct their research, get to a material, and get to market.